The expression of Insulin-like Growth Factor 2 (IGF-2) and H19, two genes located on human chromosome 11p15 and provided with cell growth modulating activity, is regulated by parental imprinting, in that the activity of their alleles is dependent on the parental origin. Parental bias in the genetic alterations of chromosome 11p15 observed in several pediatric cancers suggests the involvement of imprinted genes in tumor development. We have previously reported that the number of functional IGF-2 alleles is frequently increased in rhabdomyosarcoma (RMS), as a consequence of either relaxation of imprinting (LOI) or gene duplication. Here we show that the expression of the H19 gene is signi®cantly suppressed with respect to normal muscle tissue in 13 out of 15 rhabdomyosarcomas with embryonal histology (ERMS) and in three out of 11 rhabdomyosarcomas classi®ed as alveolar subtype (ARMS). Since a growth-inhibitory activity has been found associated with the H19 gene, the extinction of its expression can contribute to RMS development. Parental imprinting of the H19 gene was found conserved in all informative RMSs, including those whose IGF-2 imprinting was relaxed, indicating that LOI is a genespeci®c event. Seven ERMSs and one ARMS displaying low H19 RNA levels showed an underrepresentation of the expressed allele in their genotype. This result is consistent with the paternal imprinting of the H19 gene and with the preferential loss of the maternal 11p15 alleles in these neoplasms. Low H19 expression was also found in four out of eight RMSs retaining the heterozygosity at 11p15, but showing IGF-2 LOI. These ®ndings suggest that the genetic and epigenetic alterations aecting chromosome 11p15 in a high number of RMSs cause deregulation of more than one imprinted gene, possibly aecting tumor growth, including the extinction of H19 expression and an increase in the number of active IGF-2 alleles.
Keywords: genomic imprinting; 11p15 LOH; pediatric cancer Parental imprinting is a mechanism of gene regulation which causes the activity of a gene to be dependent on the gamete of origin (Efstratiadis, 1994) . Dierential expression of paternal and maternal alleles is believed to depend on epigenetic modi®cations established during gametogenesis. Most of the imprinted genes identi®ed so far are organised in clusters. Although the mechanism by which parental imprinting is established and maintained is still poorly understood, preliminary data suggest that control may be exerted on a regional basis (Kitsberg et al., 1993; Leighton et al., 1995a,b) .
An evolutionary conserved cluster of imprinted genes has been identi®ed on human chromosome 11p15.5 and on the distal part of mouse chromosome 7 (Hatada and Mukai, 1995) . Two genes with in vitro growth inhibitory capacity, namely H19 and p57 KIP2 (Hao et al., 1993; Matsuoka et al., 1995) , and a growth promoting gene activated in several human cancers, namely Insulin-like Growth Factor-2 (IGF-2), are members of such a cluster. These three genes have been shown to be parentally imprinted, with the allele of paternal origin being inactive for H19 and p57 KIP2 and the maternal allele being inactive for IGF-2 (Efstratiadis, 1994; Hatada and Mukai, 1995; Kondo et al., 1996) .
Several lines of evidence indicate that these regions of the human and mouse genomes contain genes involved in cancer development (Casola et al., 1995) . The presence of tumor suppressor gene(s) on human 11p15.5 is suggested by the frequent loss of heterozygosity (LOH) for polymorphic markers in human cancers of dierent origin (Seizinger et al., 1991) and by the observation that transfer of subchromosomal fragments can suppress the growth of embryonal tumor cells (Koi et al., 1993) . Preferential loss of maternal 11p15.5 alleles and relaxation of parental imprinting (LOI) of IGF-2 gene occur frequently in certain pediatric tumors, such as Wilms' tumor, rhabdomyosarcoma and hepatoblastoma, suggesting that abnormal expression of 11p15.5 imprinted genes have a role in the pathogenesis of these diseases (Pal et al., 1990; Scrable et al., 1989; Albrecht et al., 1994; Rainier et al., 1994 Rainier et al., , 1995 Pedone et al., 1994b) . In addition, uniparental paternal disomy (UPD) of chromosome 11p15, duplication of paternally derived 11p15, LOI of IGF-2 gene or translocation of maternal chromosome 11 with break point in 11p15 have been described in several cases of Beckwith-Wiedemann syndrome, a disease characterized by fetal hypertrophy and predisposition to development of tumors of embryonal origin (Weksberg, 1993) .
Rhabdomyosarcoma (RMS) is a pediatric solid cancer characterised by an aberrant dierentiation pattern of committed myogenic cells (Newton, 1995; Pappo, 1995) . Two major subtypes, embryonal (ERMS) and alveolar (ARMS), are known. They dier in morphologic appearance and clinical behaviour, ARMS being characterised by less favourable prognosis. Synthesis of IGF-2 is believed to have a role in the pathogenesis of RMS, since its mRNA level is increased in tumors of both subtypes and the peptide has been demonstrated to act as an autocrine growth factor in cultured RMS cells (El-Badry et al., 1990; Yun, 1992) . The involvement of 11p15 genes other than IGF-2 in RMS development is less clear, since, although IGF-2 LOI occurs in both ERMS and ARMS (Pedone et al., 1994b; Zhan et al., 1994) , LOH for 11p15 markers has only been observed in tumors belonging to the embryonal subtype (Scrable et al., 1989b) . Instead, speci®c translocations, involving PAX3 on chromosome 2q35 or PAX7 on chromosome 1p36 and the FKHR gene on chromosome 13q14 and generating novel chimaeric transcription factors, have been described in several cases of ARMS (Galili et al., 1993; Davis et al., 1994) .
In the present study we have analysed the expression and the imprinting status of the H19 gene in normal striated muscle tissue and in 15 ERMSs and 11 ARMSs and compared results with data on IGF-2 imprinting. This analysis demonstrated that parental imprinting of the H19 gene was retained in all informative RMSs, inlcuding those with LOI of the IGF-2 gene. Suppression of H19 expression relative to normal striated muscle tissue was observed in a high percentage of ERMS (13/15), but in a minor proportion of ARMS (3/ 11). Determination of tumor genotype and imprinting status indicated that a low H19 RNA level was associated with loss of the maternal allele or with relaxation of IGF-2 imprinting, although LOI of IGF-2 gene was not necessarily coupled to low H19 expression in both ERMS and ARMS.
Conservation of H19 imprinting in RMS
We have previously reported a study on the IGF-2 alleles in RMS, demonstrating that a high percentage of these neoplasms had the IGF-2 imprinting relaxed or else showed a genotype alteration with the silent IGF-2 allele underrepresented with respect to the active one (Pedone et al., 1994b) .
We have now examined the imprinting status of the H19 gene in normal striated muscle tissues and in 26 surgical tumor samples classi®ed as rhabdomyosarcomas by histological appearance (Table 1 ). The collection of neoplastic tissues included 15 ERMSs and 11 ARMSs. The H19 alleles were analysed by 
H19 imprinting in rhabdomyosarcoma S Casola et al polymerase chain reaction (PCR) on DNA and RNA extracted from tissues, using RsaI and AluI RFLPs present in the transcribed region of the gene (Zhang and Tycko, 1992) . Two samples of normal adult striated muscle tissue were found heterozygous for the RsaI RFLP ( Figure 1a ). RT ± PCR analysis of their RNAs showed expression of a single parental allele, demonstrating conservation of genomic imprinting of the H19 gene in normal muscle. Genotype analysis of the RMS samples revealed 14 informative cases for the AluI or RsaI RFLPs (Table 1) . When tumor DNA was compared with DNA obtained from normal tissue, six samples (ERMS-5, ERMS-8, ERMS-9, ERMS-10, ERMS-11 and ARMS-11) showed an imbalance of the H19 alleles, indicating loss of the constitutional heterozygosity (LOH) at the H19 locus in these neoplasms ( Figure 1b and Table 1 ). The RT ± PCR analysis of the RNA extracted from LOH samples indicated that the H19 allele preferentially retained in these tumors was not expressed or else expressed at levels lower than the other allele (ERMS-8), whereas the only active allele or the higher expressed one was underrepresented in tumor genotypes ( Figure 1b and Table 1 ). In addition, only one allele of the H19 gene was ampli®ed by RT ± PCR from the RNA of the RMSs retaining the heterozigosity ( Figure 1c and Table 1 ). These data, therefore, indicate that H19 imprinting was maintained in all RMSs studied. Genotype and expression of the IGF-2 alleles were also analysed in normal muscle and RMS samples, by following ApaI RFLP and the 5'-(VNTR-L) and 3'-part (VNTR-R) of a long dinucleotide repeat, present in the transcribed region of the gene (Pedone et al., 1994b) . Results are summarized in Table 1 and representative samples are shown in Figure 1 . The RT ± PCR analysis showed expression of a single parental allele in the informative samples of normal muscle, indicating conservation of IGF-2 imprinting in this tissue, as already reported by Pedone et al. (1994b) (Figure 1a ). Six informative RMS samples (ERMS-1, ERMS-4, ERMS-5, ERMS-9, ERMS-10 and ARMS-11) showed an imbalance of the IGF-2 alleles, with the silent allele underrepresented with respect to the expressed one ( Figure 1 and Table 1) . Figure 1 Representative results of an analysis of allele-speci®c expression of the H19 and IGF-2 genes in normal striated muscle and RMS. H19 and IGF-2 alleles were analysed by PCR and RT ± PCR in bioptic samples of normal striated muscle tissue (a), in the informative RMSs showing loss of the constitutional heterozygosity (b) and in the RMSs retaining the heterozygosity (c). H19 alleles were detected in DNA and RNA extracted from tissues by standard methods (Sambrook et al., 1989; Chomczynski and Sacchi, 1987) , using primers speci®c for the RsaI RFLP (Zhang and Tycko, 1992) : A: 5'-GCACTAAGTCATTTGCACTG-3' (sense) and B: 5'-GGTCGGAGCTTCCAGACTAG-3' (antisense) or with primers speci®c for the AluI RFLP (Zhang and Tycko, 1992) : C: 5'-TGCTGCACTTTACAACCACTG-3' (sense) and D: 5'-GTGGCCATGAAGATGGAGTC-3' (antisense). The fast migrating band observed in all of the lanes corresponding to the RsaI RFLP and indicated by an asterisk is an artefact, probably due to primer oligomerization. 0.5 mg of genomic DNA was ampli®ed in 25 ml with 1 unit Taq DNA polymerase (Stratagene) and in the presence of [ 32 P]dGTP, using an initial denaturation step of 2 min 30 s at 958C followed by 30 ± 35 cycles at 948C for 1 min, 588C for 1 min and 728C for 1 min. PCR products were digested with either RsaI or AluI and electrophoresed on a 6% non denaturing polyacrylamide gel. For detection of the expressed alleles, 0.5 ± 1 mg total RNA were reverse transcribed using 200 units of Superscript RT (BRL) in the presence of 500 nM random hexamers (Boehringer), 10 mM DTT, 50 mM Tris-HCl-pH 8.3, 75 mM KCl, 3 mM MgCl 2 , 0.5 mM dNTP-lithium salt (Boehringer) and 20 units of RNase inhibitor (Promega). One ®ftieth of ®rst strand cDNA was ampli®ed following the conditions used for genomic DNA except that the number of cycles were increased to 35 ± 40. The presence of each allele in the cDNA was identi®ed as described for genomic DNA. To control for contamination by genomic DNA, all RNA samples were run in duplicate with or without addition of reverse transcriptase. RNA samples found contaminated with genomic DNA were treated for 30 min with 1 unit of RQ RNase-free DNase (Promega) at 378C in the presence of 40 mM TrisHCl-pH 7.6, 10 mM NaCl, 6 mM MgCl 2 , 100 mM CaCl 2 . IGF-2 alleles were detected using primers speci®c for the ApaI RFLP or for the VNTR present in an untranslated region of the gene, as previously described (Pedone et al., 1994b) . See Table 1 for complete results and details on the polymorphisms H19 imprinting in rhabdomyosarcoma S Casola et al All RMS samples having an imbalance of the H19 alleles also showed, if informative, imbalances of the IGF-2 alleles and vice versa ( Table 1 ). The expressed H19 and the silent IGF-2 were the underrepresented alleles in the genotype of all LOH tumor samples (Table 1) . These alleles very likely correspond to those of maternal origin, on the basis of the reciprocal imprinting of the two genes. Biallelic expression indicating relaxation of the IGF-2 imprinting was observed in eight out of nine RMSs retaining the heterozygosity ( Figure 1c and Table 1 ). Data obtained from ARMS-2, ARMS-7 and ARMS-8 indicate that imprinting of the IGF-2 and H19 genes was not concordant, since biallelic IGF-2 expression corresponds to conservation of H19 imprinting in these sarcomas ( Figure 1c and Table 1 ).
In order to investigate the nature of the allelic imbalances detected by PCR, the copy number of the H19 gene per haploid genome was measured by Southern blot hybridization in ®ve LOH RMSs (Figure 2 ). DNAs extracted from tumors and from one normal striated muscle sample were digested with RsaI and hybridized to probes speci®c for H19 and for an unlinked marker (u-PA gene on chromosome 10), in order to compensate for loading dierences. DNAs extracted from leukocytes of three normal individuals, heterozygous and homozygous for the a and b alleles, respectively, were also analysed, as controls. H19 gene dosage was calculated by comparing densitometrically quanti®ed signals of tumor and normal samples ( Table  1) . The three RMS samples (ERMS-8, ERMS-5 and ARMS-11) informative for the RsaI RFLP showed strong allelic imbalances, with one allele ®ve-tenfold more abundant than the other. Overall the H19 gene was found to be present in 0.90 ± 1.20 allelic copies per haploid genome. ERMS-1 and ERMS-4 had the IGF-2 alleles imbalanced, but were not informative at the H19 locus, as also assessed by PCR analysis. However, allelic imbalances at 11p15 loci both centromeric (p57
KIP2
) (Hoovers et al., 1995) and telomeric (HRAS) (van Heyningen and Little, 1995) to the IGF-2/H19 region were observed in these RMS samples (data not shown). These results are compatible with the accompanying loss of maternal 11p15 alleles and duplication of the corresponding paternal alleles in these ®ve RMSs. The residual maternal allele detected by PCR ampli®cation in these samples is very likely derived from normal cells contaminating the neoplastic tissue.
Expression levels of the H19 gene in RMS
Expression of the H19 gene was investigated in normal muscle and RMS samples (Figure 3a and b) . One normal (NSM-3) and six tumor sample (ERMS-1, ERMS-2, ERMS-13, ERMS-15, ARMS-8 and ARMS-9) of which enough RNA was available, were analysed by Northern blot hybridization (Figure 3a) . In all other samples H19 RNA levels were measured by quantitative RT ± PCR (Figure 3b ). In the latter case, PCR assays with H19-speci®c primers were carried out on amounts of RMS RNA producing comparable GAPDH PCR products, for a number of cycles at which there appeared to be a linear relationship between the amount of ampli®ed product and of input RNA sample. The analysis of some of the samples by both Northern and PCR-based methods demonstrated that the results were comparable ( Figure  3a and b). Relative H19 RNA levels of normal striated muscle tissues and RMSs are reported in Table 1 . These data show that the H19 gene is actively transcribed in human striated muscle tissue, as also reported by Leibovitch et al. (1991) , but shows heterogeneous expression in RMS samples. If tumor samples are grouped according to the histotype, results obtained show that H19 RNA levels in 13/15 ERMSs were two-to 100-fold lower than normal adult striated muscle, whereas 8/11 ARMSs expressed equivalent or higher H19 RNA levels than normal tissues. All LOH RMS showed low H19 expression, consistent with the demonstrated loss of the active allele and with conservation of parental imprinting of this gene in the tumors. Four of the eight RMSs (ERMS-2, ERMS-3, ARMS-8 and ARMS-10) exhibiting LOI of IGF-2 gene had H19 RNA levels two-to 30-fold lower than normal muscle, but the other four (ERMS-15, ARMS-2, ARMS-5 and ARMS-7) showed normal expression levels. ERMS-7, a sample with equally balanced 11p15 alleles and normal IGF-2 imprinting, had H19 RNA levels comparable to normal tissue. Figure 2 Determination of H19 allelic dosage in RMS. 10 mg DNA extracted from ®ve RMSs, one normal striated muscle and three blood samples from normal individuals, were digested with RsaI, blotted and hybridized sequentially to 32 P-labelled H19 and u-PA (chromosome 10) probes. Southern blot analysis was carried out essentially as described (Sambrook et al., 1989; Church and Gilbert, 1984) . 32 P-labelled probes were generated by random priming extension (Feinberg and Vogelstein, 1984 ) from a PCR ampli®cation product of human H19 cDNA (primers A and B) and from a restriction fragment isolated from human urokinaseplasminogen activator (u-PA) cDNA (Verde et al., 1984) NSM-3 ERMS-1 ERMS-2 ERMS-13 ARMS-8 ARMS-9 ERMS-15
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NSM-2 NSM-3 ERMS-5 ERMS-6 ERMS-7 ERMS-8 ARMS-2 ARMS-5 ARMS-7 ARMS-8 ARMS-10 b Figure 3 Expression of the H19 gene in normal striated muscle and RMS. (a) H19 mRNA levels in normal and neoplastic muscle tissues, as revealed by Northern blot analysis. 10 ± 20 mg total RNA extracted from one normal striated muscle and six RMS samples were blotted and hybridized sequentially to 32 P-labelled H19 and 28S rRNA probes, as described (Sambrook et al., 1989; Church and Gilbert, 1984) . The oligonucleotide 5'-AACGATCA-GAGTAGTGGTATTTCACC-3', speci®c for 28S ribosomal RNA, was used to correct for RNA loading dierences (Barbu and Dautry, 1989) . (b) H19 mRNA levels in normal and neoplastic muscle tissues, as revealed by quantitative RT ± PCR analysis. A procedure modi®ed from Pedone et al. (1994a) was used. 0.5 ± 1.0 mg total RNA were reverse transcribed. Amounts of cDNA producing comparable GAPDH RT ± PCR products and roughly equivalent to 15, 30 and 60 ng of total RNA were ampli®ed with GAPDH-and H19-speci®c primers in the presence of [a-32 P]dATP. GAPDH-speci®c primers were: E: 5'-CAC-CATCTTCCAGGAGCGAG-3' and F: 5'-TCACGCCACAGT-TTCCCGGA-3'. Conditions were chosen to give a linear relationship between the amount of ampli®ed product and the input RNA. For GAPDH ampli®cation the conditions used were: initial denaturation at 958C for 2 min 30 s followed by 20 cycles at 948C for 1 min, 568C for 1 min and 728C for 1 min. The GAPDH-speci®c product was 373 bp long. Primers C and D were used for H19 RT ± PCR ampli®cation. Conditions were: initial denaturation at 958C for 2 min 30 s followed by 20 cycles at 94 for 1 min, 588 for 1 min and 728 for 1 min. Equal volumes of PCR samples were electrophoresed on a 6% non denaturing polyacrylammide gel and quanti®ed by densitometric scanning of the dried gel using a Phosphorimager desitometer with ImageQuant TM Software (Molecular Dynamics)
Molecular cloning of the PAX-FKHR fusion genes generated by t(2; 13) and t(1; 13) translocations in RMS has made it possible to detect the presence of the chimaeric transcripts derived from der(13) t(2: 13) and der(13) t(1; 13) in tumor samples (Galili et al., 1993; Davis et al., 1994) by RT ± PCR. We screened the RMSs for the presence of transcripts derived from fusion genes, using PAX3-and FKHR-or PAX7-and FKHR-speci®c primers (Figure 4 and Table 1 ). The PAX3-FKHR transcript was ampli®ed from six ARMSs and PAX7-FKHR from four ARMSs out of 11 RMSs with alveolar histology, although the two types of chimaeric transcripts were never detected in the same tumor sample. The wild-type FKHR transcript, originating from unrearranged chromosome 13 was RT ± PCR ampli®ed in all samples, as a control. Neither PAX-FKHR transcripts were ampli®ed from RNAs extracted from ERMS samples and no correlation was observed between occurrence of t(2; 13) or t(1; 13) translocations and H19 RNA levels in RMS.
Genetic and epigenetic alterations observed in cancers of embryonal origin suggest that imprinted genes located on chromosome 11p15 have a role in tumor development . How these events can aect tumor development is a matter of speculation. It is possible that loss of maternal alleles could cause extinction of a paternally inactive imprinted gene with tumor suppressor activity. The consequence of imprinting relaxation on gene expression is more dicult to predict, since the molecular mechanisms responsible for dierential activity of paternal and maternal alleles are still unde®ned. The simplest interpretation is that LOI, like UPD and duplication of paternally derived 11p15, causes overexpression of an imprinted growth promoting gene, such as IGF-2, because it increases the number of active alleles. Consistent with this hypothesis, the use of gene disrupted mice has demonstrated that the activation of both IgP-2 alleles contribute to tumor development in an experimental system of pancreatic carcinogenesis (Christofori et al., 1995) . On the other hand, it has been reported that a 20-to 80-fold suppression of H19 RNA levels is associated with LOI of the IGF-2 gene in Wilms tumor, suggesting that a reduction in H19 expression by an epigenetic mechanism related to LOI or by loss of the maternal allele due to LOH is a key event in the development of this neoplasm (Steenman et al., 1994; Moulton et al., 1994; Taniguchi et al., 1995) . Interestingly, mice inheriting a deletion of the H19 gene from their mothers lose IgP-2 imprinting, suggesting that expression of the H19 and IgP-2 genes on each chromosome is linked, possibly because of competition for shared regulatory elements (Leighton et al., 1995a,b) . Such a relationship between IgP-2 imprinting and H19 expression was not observed in two analyses of human hepatoblastomas (Rainier et al., 1995; Li et al., 1995) .
Our study shows that the expression of the H19 gene is signi®cantly suppressed with respect to normal striated muscle tissue in the majority of a group of 15 RMSs of embryonal subtype and in a minority of 11 alveolar RMSs. The ®nding of a low H19 RNA level is consistent with the observed conservation of parental imprinting of the H19 gene in seven ERMSs and one ARMS showing loss of 11p15 alleles of maternal origin. Two additional ERMSs and two ARMSs with H19 expression lower than normal muscle have normally balanced 11p15 alleles, but showed a relaxed imprinting of the IGF-2 gene. On the contrary, the only informative ERMS with equally balanced 11p15 alleles and conservation of IGF-2 imprinting (ERMS-7) has H19 RNA levels comparable to normal tissue. However, relaxation of IGF-2 imprinting is not always coupled to abolishment of H19 expression, since one ERMS and three ARMSs with IGF-2 LOI showed normal H19 RNA levels. These results indicate a weak correlation between IGF-2 imprinting and H19 expression, rather than the tight dependence suggested by results obtained in mice and in Wilms tumor samples (Leighton et al., 1995a; Steenman et al., 1994; Moulton et al., 1994) . Mechanisms causing biallelic activation of the IGF-2 gene, without aecting H19 expression and imprinting status can therefore occur in neoplastic cells.
The functional role of the H19 gene in muscle as well as in other tissues has not been de®nitely established. The H19 transcript is very abundant in the developing mouse embryo and is down-regulated in the adult animal, with the exception of muscle tissue (Pachnis et al., 1984) . Studies on muscle cell lines demonstrate a positive correlation between H19 expression and myogenic dierentiation (Pachnis et al., 1988; Davis et al., 1987; Leibovitch et al., 1995) . Forced expression of the transfected H19 gene inhibited cell growth of a rhabdomyosarcoma cell line and suppressed tumorigenicity of Wilms' tumor cells (Hao et al., 1993) . Low H19 RNA levels relative to 1 2 3 4 5 6 7 8 9 10 11 Figure 4 Detection of PAX/FKHR fusion and FKHR transcripts by RT ± PCR in ARMS samples. Fusion transcripts derived from t(2;13)(p36;q14) and t(1;13) (q35;q14) translocations were detected by RT ± PCR, as previously described (Galili et al., 1993; Davis et al., 1994) . The wild-type FKHR transcript was RT ± PCR ampli®ed as control. Primers used to detect the PAX7-FKHR (1;13) transcript were: G: 5'-CTGACAGCTTCATGAATCCGG-3' (sense) and H: 5'-CATCATTGCTGTGAGAGCCAG-3' (antisense). The PAX3-FKHR (2;13) transcript was ampli®ed with primer: I: 5'-AGACAGCTTTGTGCCTCCGTC-3' (sense) and primer H (antisense). The FKHR transcript was ampli®ed with primer. J: 5'-GCAGATCTACGAGTGGATGGT-3' (sense) and primer H (antisense). Conditions for PAX7-FKHR amplification were: initial denaturation at 958C for 2 min 30 s followed by 40 cycles at 948 for 1 min, 608C for 1 min and 728C for 1 min. PAX3-FKHR and wt-FKHR were ampli®ed as before except for the hybridization temperature, which was 568C. Ampli®ed fragments of 357 bp, 359 bp and 365 bp fragments were visualised by electrophoresis on a 2% agarose gel and identi®ed as speci®c for PAX7-FKHR, PAX3-FKHR or wild-type FKHR transcripts, respectively, by Southern blot hybridization and restriction enzyme digestion normal tissues have been found in the great majority of Wilms' tumor samples, suggesting the role of a tumor suppressor for this gene (Steenman et al., 1994; Moulton et al., 1994; Taniguchi et al., 1995) . The low expression level we have detected in most of the ERMS analysed is consistent with such an activity for the H19 gene in this subtype of RMS. On the other hand, it cannot be excluded that the extinction of H19 expression is a passive consequence of the loss of maternal 11p15 alleles in the LOH RMSs and part of a mechanism causing a disturbance of parental imprinting in the LOI RMSs. Still unde®ned is the mechanism of action of the H19 gene product, since the gene does not encode any protein, but rather an untranslated RNA (Brannan et al., 1990) . It has been suggested that the H19 RNA works as a regulator of imprinting, by analogy with the regulatory role for X chromosome inactivation proposed for the Xist transcript (Pfeier and Tilghman, 1994) . The growth modulatory properties of the H19 gene could then be an indirect eect, due to a modi®cation of 11p15 imprinted gene expression.
PAX7/FKHR PAX3/FKHR wt-FKHR
Both 11p15 and IGF-2 LOI cause an increase in the number of active IGF-2 alleles, since loss of maternal 11p15 alleles in RMS is frequently coupled with the duplication of the corresponding paternal alleles. LOI of the IGF-2 gene occurs in the ERMS and ARMS samples retaining the heterozygosity more frequently than the abolishment of H19 expression (8/9 versus 4/9). The only RMS sample (ERMS-7) showing normally balanced 11p15 alleles and conservation of IGF-2 imprinting had botrioid histology, a variant RMS characterised by a more favourable prognosis (Newton, 1995) . The activation of this growth promoting gene by genetic or epigenetic mechanisms is thus very likely to be an important step in the progression of both embryonal and alveolar RMS. The activation of protooncogenes, such as N-RAS, N-MYC and MET and the inactivation of tumor suppressor genes, such as RB and p53 have also been proposed to in¯uence the malignancy of these neoplasms (Ferracini et al., 1996) . It would be interesting to determine if the expression or activity of other imprinted genes with growth modulatory capacity, such as p57
KIP2
, is aected in RMS.
Reduction of H19 expression is not a frequent event in RMS of the alveolar subtype and probably does not play a major role in the development of this type of sarcoma. More relevant for ARMS progression might be the generation of PAX-FKHR transcription factor genes, as a consequence of t(1; 13) or t(2: 13) translocations. In our study, PAX3-FKHR or PAX7-FKHR transcripts were detected in 10/11 ARMS samples. No correlation was found between PAX-FKHR fusions and H19 RNA levels. A high frequency of PAX-FKHR translocations has also been observed by Barr et al. (1995) in a study of 28 cases of ARMS. Although our investigation was carried out on fewer cases, it is worth noting that the ratio between PAX3-FKHR and PAX7-FKHR fusions we have detected (6 : 4) diers signi®cantly from that previously reported (18 : 4). LOH of 11p15 loci is not a common feature of ARMS, although it is very frequent in ERMS. In one case (ARMS-11) histologically diagnosed as ARMS, we have observed both the LOH of H19 and IGF-2 alleles and the presence of a PAX3-FKHR transcript. This ®nding suggests that the alveolar and embryonal subtypes of RMS arise from the same type of myogenic cell and that the occurrence of speci®c molecular events, such as the generation of PAX-FKHR fusion genes by chromosome translocations, may dominantly in¯uence the evolution of the disease toward the more unfavourable behaviour of ARMS.
